AlphaFold predicted structure
RIPOR2 · Q9Y4F9

Mean pLDDT
65.3/ 100
Low
1,068 residues
Confidence breakdown
- Very high(≥ 90)30%
- Confident(70–90)23%
- Low(50–70)5%
- Very low(< 50)41%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
RHO family interacting cell polarization regulator 2
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Monogenic hearing loss
BOTH monoallelic and biallelic, autosomal or pseudoautosomalhearing loss, autosomal recessive
deafness
autosomal dominant nonsyndromic hearing loss
nonsyndromic genetic hearing loss
Non-syndromic genetic deafness
iron metabolism disease
rheumatoid arthritis
mineral metabolism disease
dementia
metabolic disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Rho family-interacting cell polarization regulator 2
Acts as an inhibitor of the small GTPase RHOA and plays several roles in the regulation of myoblast and hair cell differentiation, lymphocyte T proliferation and neutrophil polarization (PubMed:17150207, PubMed:23241886, PubMed:24687993, PubMed:24958875, PubMed:25588844, PubMed:27556504). Inhibits chemokine-induced T lymphocyte responses, such as cell adhesion, polarization and migration (PubMed:23241886). Involved also in the regulation of neutrophil polarization, chemotaxis and adhesion (By similarity). Required for normal development of inner and outer hair cell stereocilia within the cochlea of the inner ear (By similarity). Plays a role for maintaining the structural organization of the basal domain of stereocilia (By similarity). Involved in mechanosensory hair cell function (By similarity). Required for normal hearing (PubMed:24958875)
RIPOR2 · Q9Y4F9

Mean pLDDT
65.3/ 100
Low
1,068 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0